Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, 3307 N Broad Street, Philadelphia, PA 19140 USA.
Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine, 3701 Market Street, 8th Floor, Philadelphia, PA 19119 USA.
Clin Epigenetics. 2015 Apr 8;7(1):41. doi: 10.1186/s13148-015-0071-7. eCollection 2015.
We, and others, have demonstrated previously that there are differences in DNA methylation and transcript levels of a number of genes in cord blood and placenta between children conceived using assisted reproductive technologies (ART) and children conceived in vivo. The source of these differences (the effect of ART versus the underlying infertility) has never been determined in humans. In this study, we have attempted to resolve this issue by comparing placental DNA methylation levels at 37 CpG sites in 16 previously identified candidate genes in independent populations of children conceived in vivo ('fertile control' group) with ART children conceived from two groups: either autologous oocytes with infertility in one or both parents ('infertile ART' group) or donor oocytes (obtained from young fertile donors) without male infertility ('donor oocyte ART' group).
Of the 37 CpG sites analyzed, significant differences between the three groups were found in 11 CpGs (29.73 %), using ANOVA. Tukey's post hoc test on the significant results indicated that seven (63.63 %) of these differences were significant between the donor oocyte ART and fertile control groups. In addition, 20 of the 37 CpGs analyzed had been identified as differentially methylated between ART and fertile control groups in an independent population in a prior study. Of these 20 CpG sites, 9 also showed significant differences in the present population. An additional 9 CpGs were found to be significantly different between the two groups. Of these 18 candidate CpGs, 12 CpGs (in seven candidate genes) also showed significant differences in placental DNA methylation levels between the donor oocyte ART and fertile control groups.
These data suggest strongly that the DNA methylation differences observed between ART and in vivo conceptions are associated with some aspect of ART protocols, not simply the underlying infertility.
我们和其他人之前已经证明,在使用辅助生殖技术(ART)受孕的儿童和体内受孕的儿童的脐带血和胎盘的许多基因的 DNA 甲基化和转录水平存在差异。这些差异的来源(ART 的影响与潜在的不孕)在人类中从未被确定过。在这项研究中,我们试图通过比较来自两个群体的 ART 儿童和体内受孕的儿童(“有活力的对照组”)的胎盘 DNA 甲基化水平来解决这个问题,这两个群体分别是:父母一方或双方不孕的自体卵(“不孕 ART”组)或来自年轻健康供体的供体卵(“供体卵 ART”组)。
在分析的 37 个 CpG 位点中,使用 ANOVA 发现三组之间有 11 个 CpG 位点存在显著差异。对显著结果进行 Tukey 事后检验表明,其中 7 个(63.63%)差异在供体卵 ART 组和有活力的对照组之间是显著的。此外,在之前的一项独立人群研究中,已经确定 37 个 CpG 中有 20 个在 ART 和有活力的对照组之间存在差异甲基化。在本研究中,这 20 个 CpG 中有 9 个也存在显著差异。另外还有 9 个 CpG 在两组之间存在显著差异。在这 18 个候选 CpG 中,有 12 个 CpG(在七个候选基因中)在供体卵 ART 组和有活力的对照组之间的胎盘 DNA 甲基化水平也存在显著差异。
这些数据强烈表明,在 ART 和体内受孕之间观察到的 DNA 甲基化差异与某些 ART 方案有关,而不仅仅是潜在的不孕。